SCHEMBL22792573

SCHEMBL22792573

CC(C)(C)c1c2ccsc2cn1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22792423 0.81 KDM4E (0.32) —
SCHEMBL22792587 0.78 CCR9 (0.31) —
SCHEMBL21931153 0.67 ALDH1A1 (0.32) —
SCHEMBL22793158 0.67 EGFR (0.33) —
SCHEMBL22792420 0.64 DRD1 (0.30) —
SCHEMBL23346675 0.64 CCR9 (0.33) —
SCHEMBL18418916 0.61 BRD4 (0.32) —
SCHEMBL24188609 0.60 — —
SCHEMBL24188649 0.60 NTRK1 (0.33) —
SCHEMBL24188614 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200392128-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2020-12-17 — — US disclosed
Send feedback